Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A04167 | 33731171 | Nutr Metab (Lond) | Neck circumference as an independent predictor for NAFLD among postmenopausal women with normal body mass index. | 2021 | Details |
| A04168 | 33730774 | Ultrasonography | Severity of hyperechoic pancreas on ultrasonography as a risk factor for glycemic progression. | 2021 | Details |
| A04169 | 33730435 | Hepatology | In Utero Exposure to Mercury Is Associated With Increased Susceptibility to Liver Injury and Inflammation in Childhood. | 2021 | Details |
| A04170 | 33729777 | J Agric Food Chem | Dietary Polyphenols to Combat Nonalcoholic Fatty Liver Disease via the Gut-Brain-Liver Axis: A Review of Possible Mechanisms. | 2021 | Details |
| A04171 | 33728991 | Am J Physiol Gastrointest Liver Physiol | Mitochondrial DNA enables AIM2 inflammasome activation and hepatocyte pyroptosis in nonalcoholic fatty liver disease. | 2021 | Details |
| A04172 | 33728819 | FEBS Open Bio | The role of SAMM50 in non-alcoholic fatty liver disease: from genetics to mechanisms. | 2021 | Details |
| A04173 | 33728708 | Phytother Res | Effect of Nigella sativa in the treatment of nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. | 2021 | Details |
| A04174 | 33728021 | Oxid Med Cell Longev | Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application. | 2021 | Details |
| A04175 | 33727836 | Diabetes Metab Syndr Obes | Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice. | 2021 | Details |
| A04176 | 33727658 | Commun Biol | Adiponectin-expressing Treg facilitate T lymphocyte development in thymic nurse cell complexes. | 2021 | Details |
| A04177 | 33727164 | Clin Gastroenterol Hepatol | Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2021 | Details |
| A04178 | 33726979 | Dig Liver Dis | Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine. | 2021 | Details |
| A04179 | 33726778 | Chin Med | Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat. | 2021 | Details |
| A04180 | 33725855 | Medicine (Baltimore) | Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2021 | Details |
| A04181 | 33724516 | Hepatology | Steatotic Hepatocytes Release Mature VLDL Through Methionine and Tyrosine Metabolism in a Keap1-Nrf2-Dependent Manner. | 2021 | Details |
| A04182 | 33724511 | Hepatology | Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A04185 | 33723650 | Acta Diabetol | The long-term metabolic and neurocognitive risks in offspring of women with type 1 diabetes mellitus. | 2021 | Details |
| A04186 | 33723340 | Sci Rep | Elevation of plasma tRNA fragments as a promising biomarker for liver fibrosis in nonalcoholic fatty liver disease. | 2021 | Details |
| A04187 | 33723094 | Saudi J Gastroenterol | Surveillance for hepatocellular carcinoma in patients with advanced liver fibrosis. | 2021 | Details |
| A04188 | 33722778 | Clin Res Hepatol Gastroenterol | Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis. | 2021 | Details |
| A04189 | 33722690 | Mol Metab | Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression. | 2021 | Details |
| A04190 | 33722154 | Adipocyte | Dysfunctional adiposity index as a marker of adipose tissue morpho-functional abnormalities and metabolic disorders in apparently healthy subjects. | 2021 | Details |
| A04191 | 33721575 | Clin Imaging | Non-invasive imaging biomarkers to assess nonalcoholic fatty liver disease: A review. | 2021 | Details |
| A04192 | 33721354 | Clin Exp Pharmacol Physiol | Sodium butyrate ameliorates non-alcoholic fatty liver disease by upregulating miR-150 to suppress CXCR4 expression. | 2021 | Details |
| A04193 | 33720620 | Ter Arkh | [Hepatocellular damage and inflammation in various forms of alcoholic liver disease]. | 2021 | Details |
| A04194 | 33720580 | Ter Arkh | [Mixed steatohepatitis: more questions than answers (Part 1)]. | 2020 | Details |
| A04195 | 33720570 | Ter Arkh | [Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease]. | 2020 | Details |
| A04196 | 33720280 | Biochem J | α-Methyl-l-tryptophan as a weight-loss agent in multiple models of obesity in mice. | 2021 | Details |
| A04197 | 33720087 | J Pediatr Gastroenterol Nutr | Pediatric Non-Alcoholic Fatty Liver Disease Is Affected by Genetic Variants Involved in Lifespan/Healthspan. | 2021 | Details |
| A04198 | 33720049 | J Clin Invest | VCAM-1: closing the gap between lipotoxicity and endothelial dysfunction in nonalcoholic steatohepatitis. | 2021 | Details |
| A04199 | 33719959 | Curr Pharm Des | The Effect of Metformin on Aminotransferase Levels, Metabolic Parameters and Body Mass Index in Nonalcoholic Fatty Liver Disease Patients: A Metaanalysis. | 2021 | Details |
| A04200 | 33718398 | Front Med (Lausanne) | Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review. | 2021 | Details |
| A04201 | 33716968 | Front Endocrinol (Lausanne) | Alternative RNA Splicing in Fatty Liver Disease. | 2021 | Details |
| A04202 | 33716495 | Curr Treat Options Gastroenterol | An update on the role of the microbiome in non-alcoholic fatty liver disease pathogenesis, diagnosis, and treatment. | 2020 | Details |
| A04203 | 33716447 | World J Gastroenterol | G protein-coupled receptors as potential targets for nonalcoholic fatty liver disease treatment. | 2021 | Details |
| A04204 | 33716004 | Metabolism | Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes. | 2021 | Details |
| A04205 | 33715205 | Clin Endocrinol (Oxf) | Relationship between de novo lipogenesis and serum sex hormone binding globulin in humans. | 2021 | Details |
| A04206 | 33714861 | Complement Ther Clin Pract | Effect of green coffee bean extract supplementation on liver function and inflammatory biomarkers: A meta-analysis of randomized clinical trials. | 2021 | Details |
| A04207 | 33713358 | Hepatology | TNF-α-Induce Protein 8-Like 1 Inhibits Hepatic Steatosis, Inflammation, and Fibrosis by Suppressing Polyubiquitination of Apoptosis Signal-Regulating Kinase 1. | 2021 | Details |
| A04208 | 33713286 | Intern Emerg Med | Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study. | 2021 | Details |
| A04209 | 33712680 | Sci Rep | Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma. | 2021 | Details |
| A04211 | 33711964 | BMC Pediatr | Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity. | 2021 | Details |
| A04212 | 33711631 | Clin Res Hepatol Gastroenterol | The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study. | 2021 | Details |
| A04213 | 33711479 | Clin Gastroenterol Hepatol | Treatment Candidacy for Pharmacologic Therapies for NASH. | 2021 | Details |
| A04214 | 33711421 | J Nutr Biochem | Dietary cocoa ameliorates non-alcoholic fatty liver disease and increases markers of antioxidant response and mitochondrial biogenesis in high fat-fed mice. | 2021 | Details |
| A04215 | 33710478 | Glycoconj J | MALDI-TOF mass spectrometry imaging for N-glycans on FFPE tissue sections of mouse NASH liver through Sialic acid Benzylamidation. | 2021 | Details |
| A04216 | 33709875 | Expert Rev Gastroenterol Hepatol | Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease? | 2021 | Details |
| A04217 | 33709647 | Eur J Transl Myol | Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2021 | Details |
| A04218 | 33709607 | J Gastroenterol Hepatol | Artificial intelligence in prediction of non-alcoholic fatty liver disease and fibrosis. | 2021 | Details |
| A04219 | 33709606 | J Gastroenterol Hepatol | Artificial intelligence in precision medicine in hepatology. | 2021 | Details |
| A04220 | 33709507 | Jpn J Nurs Sci | Quality of Life in patients with nonalcoholic fatty liver disease: Structure and related factors focusing on illness uncertainty. | 2021 | Details |
| A04221 | 33709477 | J Gastroenterol Hepatol | Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A04222 | 33708919 | Ann Transl Med | Effects of earthworm extract on the lipid profile and fatty liver induced by a high-fat diet in guinea pigs. | 2021 | Details |
| A04223 | 33708783 | Front Med (Lausanne) | Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A04224 | 33708352 | World J Hepatol | Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us? | 2021 | Details |
| A04225 | 33708180 | Front Microbiol | Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota. | 2021 | Details |
| A04226 | 33708118 | Front Pharmacol | Astragaloside IV Improves High-Fat Diet-Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway. | 2021 | Details |
| A04227 | 33707081 | Best Pract Res Clin Endocrinol Metab | Gut microbiome and bile acids in obesity-related diseases. | 2021 | Details |
| A04228 | 33706959 | Vitam Horm | Ghrelin and adipokines: An overview of their physiological role, antimicrobial activity and impact on cardiovascular conditions. | 2021 | Details |
| A04229 | 33706839 | Epidemiol Psychiatr Sci | Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity. | 2021 | Details |
| A04230 | 33705952 | J Nutr Biochem | n-3 PUFAs protect against adiposity and fatty liver by promoting browning in postnatally overfed male rats: a role for NRG4. | 2021 | Details |
| A04231 | 33705945 | J Nutr Biochem | High sucrose diet-induced dysbiosis of gut microbiota promotes fatty liver and hyperlipidemia in rats. | 2021 | Details |
| A04232 | 33705650 | Diabetes Metab J | Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients. | 2021 | Details |
| A04233 | 33704100 | Clin Transl Gastroenterol | Individualized Polygenic Risk Score Identifies NASH in the Eastern Asia Region: A Derivation and Validation Study. | 2021 | Details |
| A04234 | 33703947 | J Appl Physiol (1985) | High fat high sucrose diet-induced dyslipidemia in guinea pigs. | 2021 | Details |
| A04235 | 33694195 | J Gastroenterol Hepatol | Oxidized low-density lipoprotein activates extracellular signal-regulated kinase signaling to downregulate sortilin expression in liver sinusoidal endothelial cells. | 2021 | Details |
| A04236 | 33694066 | Hepatol Int | Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD? | 2021 | Details |
| A04237 | 33693900 | J Nutr | Consumption of High-Fructose Corn Syrup Compared with Sucrose Promotes Adiposity and Increased Triglyceridemia but Comparable NAFLD Severity in Juvenile Iberian Pigs. | 2021 | Details |
| A04238 | 33693866 | J Nutr | Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice. | 2021 | Details |
| A04239 | 33693708 | J Clin Endocrinol Metab | Circulating Galectin-3 Levels Are Not Associated With Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study. | 2021 | Details |
| A04240 | 33693480 | Cardiovasc Res | Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis. | 2022 | Details |
| A04241 | 33693023 | Front Nutr | Alcohol Intake Is Associated With Elevated Serum Levels of Selenium and Selenoprotein P in Humans. | 2021 | Details |
| A04242 | 33692781 | Front Immunol | Increased Frequency of Dysfunctional Siglec-7-CD57+PD-1+ Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A04243 | 33692776 | Front Immunol | TGR5 Regulates Macrophage Inflammation in Nonalcoholic Steatohepatitis by Modulating NLRP3 Inflammasome Activation. | 2021 | Details |
| A04244 | 33692700 | Front Physiol | Characterization of the CDAA Diet-Induced Non-alcoholic Steatohepatitis Model: Sex-Specific Differences in Inflammation, Fibrosis, and Cholesterol Metabolism in Middle-Aged Mice. | 2021 | Details |
| A04245 | 33691757 | Diabetol Metab Syndr | Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. | 2021 | Details |
| A04246 | 33691721 | Nutr Metab (Lond) | Integrative proteomic and lipidomic analysis of Kaili Sour Soup-mediated attenuation of high-fat diet-induced nonalcoholic fatty liver disease in a rat model. | 2021 | Details |
| A04247 | 33691456 | Ann Palliat Med | Efficacy and safety of Huazhi Rougan granule in the treatment of non-alcoholic fatty liver: a systematic review and meta-analysis. | 2021 | Details |
| A04248 | 33691159 | Environ Res | Association between cumulative childhood blood lead exposure and hepatic steatosis in young Mexican adults. | 2021 | Details |
| A04249 | 33690979 | Small | Bioengineered Multicellular Liver Microtissues for Modeling Advanced Hepatic Fibrosis Driven Through Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A04250 | 33689525 | Arch Physiol Biochem | Effects of lacto-ovo-vegetarian diet vs. standard-weight-loss diet on obese and overweight adults with non-alcoholic fatty liver disease: a randomised clinical trial. | 2021 | Details |
| A04251 | 33689215 | J Cell Mol Med | Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway. | 2021 | Details |
| A04252 | 33688490 | Can J Gastroenterol Hepatol | Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements. | 2021 | Details |
| A04253 | 33688327 | Rev Bras Med Trab | Non-alcoholic fatty liver disease and associated risk factors in health care professionals in a community hospital in Brazil. | 2021 | Details |
| A04254 | 33688229 | Diabetes Metab Syndr Obes | Risk Factors Screening for Gestational Diabetes Mellitus Heterogeneity in Chinese Pregnant Women: A Case-Control Study. | 2021 | Details |
| A04255 | 33687678 | Methods Mol Biol | Co-Culture of Human Mesenchymal Stromal Cells and Primary Mouse Hepatocytes. | 2021 | Details |
| A04256 | 33687168 | Int J Fertil Steril | Effect of Low-Intensity Endurance Training and High-Intensity Interval Training on Sperm Quality in Male Rats with Fatty Liver. | 2021 | Details |
| A04257 | 33686111 | Sci Rep | A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgery. | 2021 | Details |
| A04258 | 33685968 | Gut | Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies. | 2021 | Details |
| A04259 | 33685807 | Dig Liver Dis | Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population. | 2021 | Details |
| A04260 | 33685086 | Zhonghua Gan Zang Bing Za Zhi | [Role of 1, 25-dihydroxyvitamin D3 in liver lipid metabolism induced by methionine-choline-deficient diet in rats]. | 2021 | Details |
| A04261 | 33685085 | Zhonghua Gan Zang Bing Za Zhi | [Correlation between PNPLA3 rs738409 and TM6SF2 rs58542926 gene polymorphism and primary liver cancer in the Han Population of China's Northeast region]. | 2021 | Details |
| A04262 | 33685078 | Zhonghua Gan Zang Bing Za Zhi | [Ten years of research progress in the field of non-viral liver disease]. | 2021 | Details |
| A04263 | 33685076 | Zhonghua Gan Zang Bing Za Zhi | [Research progress and prospect of liver cirrhosis]. | 2021 | Details |
| A04264 | 33685075 | Zhonghua Gan Zang Bing Za Zhi | [From treatable to curable to eliminated ---- a decade of research progress in the diagnosis and treatment of hepatitis C]. | 2021 | Details |
| A04265 | 33684933 | J Am Med Inform Assoc | Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis. | 2021 | Details |
| A04266 | 33684693 | Biomed Pharmacother | Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation. | 2021 | Details |
| A04267 | 33684566 | Biochim Biophys Acta Mol Cell Biol Lipids | GDF11 rapidly increases lipid accumulation in liver cancer cells through ALK5-dependent signaling. | 2021 | Details |
| A04268 | 33683797 | Int J Clin Pract | The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study. | 2021 | Details |
| A04269 | 33681678 | Hepatol Commun | High-Fat Diet Modulates Hepatic Amyloid β and Cerebrosterol Metabolism in the Triple Transgenic Mouse Model of Alzheimer's Disease. | 2020 | Details |